GlassScriptPhysician profile
Bridget T Walsh
NPI 1326139585
$749.88
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $311.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $156.47 | 2019 | |
| Genzyme Corporation | $38.16 | 2019 | |
| Pacira Therapeutics, INC. | $36.18 | 2019 | |
| Abbvie INC. | $32.83 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.01 | 2019 | |
| Lilly USA, LLC | $20.82 | 2019 | |
| Radius Health, INC. | $18.98 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.53 | 2019 | |
| Janssen Biotech, INC. | $17.13 | 2019 | |
| Horizon Therapeutics Plc | $15.68 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.40 | 2019 | |
| Orthogenrx INC. | $15.12 | 2019 | |
| Pfizer INC. | $13.44 | 2019 | |
| Glaxosmithkline, LLC. | $11.44 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.